Bioventix Share Price (BVXP)

Trade Now

Capital at risk

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Bioventix Plc	LSE:BVXP	London	Ordinary Share	GB00B4QVDF07	ORD 5P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	0.00	0.0%	3,350.00	1,750	01:00:00

Bid Price		Offer Price	High Price	Low Price	Open Price
3,300.00		3,400.00	3,350.00	3,350.00	3,350.00

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	10.31	8.23	139.41	24.0	175

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
14:18:53	O	11	3,380.00	GBX

Related Shares
Astrazeneca (AZN), Gsk (GSK), N4 Pharma (N4P), Bermele (BERM)

Bioventix (BVXP) Latest News

Bioventix News

Date	Time	Source	Headline
14/9/2022	12:11	ALNC	IN BRIEF: Bioventix expects full-year trading to surpass expectations
14/9/2022	07:00	UKREG	Bioventix Plc Trading Update & Notice of Results
25/8/2022	09:54	UKREG	Bioventix Plc Holding(s) in Company
27/7/2022	15:53	UKREG	Bioventix Plc Holding(s) in Company
26/4/2022	12:50	UKREG	Bioventix Plc Director Dealing
29/3/2022	18:05	ALNC	TRADING UPDATES: Solid 2021 for Ten Entertainment, Central Asia Metals
29/3/2022	07:00	UKREG	Bioventix Plc Interim Dividend Confirmation
28/3/2022	07:00	UKREG	Bioventix Plc Half-year Report
09/12/2021	15:41	UKREG	Bioventix Plc Result of AGM
22/11/2021	15:25	UKREG	Bioventix Plc Director/PDMR Shareholding

More Bioventix News

Bioventix Investors Bioventix Takeover Rumours

Bioventix (BVXP) Share Charts 1 Year Bioventix Chart
1 Month Bioventix Chart	Intraday Bioventix Chart

Bioventix (BVXP) Discussions and Chat

Bioventix Forums and Chat

Date	Time	Title	Posts
26/9/2022	10:57	Bioventix - Sheep Antibodies	1,424
08/11/2016	13:07	ShareSoc Supper in Brighton	-

Add a New Thread

Bioventix (BVXP) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
13:18:54	3,380.00	11	371.80	O
12:53:37	3,335.00	100	3,335.00	O
12:31:39	3,350.00	350	11,725.00	O
12:20:57	3,375.00	537	18,123.75	O
09:50:17	3,350.00	119	3,986.50	O

View all Bioventix trades in real-time

Bioventix (BVXP) Top Chat Posts

Top Posts
Posted at 29/9/2022 09:20 by Bioventix Daily Update Bioventix Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker BVXP. The last closing price for Bioventix was 3,350p. Bioventix Plc has a 4 week average price of 3,115p and a 12 week average price of 3,115p. The 1 year high share price is 3,980p while the 1 year low share price is currently 2,915p. There are currently 5,209,333 shares in issue and the average daily traded volume is 2,783 shares. The market capitalisation of Bioventix Plc is £174,512,655.50. Read Full Thread Reply
Posted at 26/9/2022 10:57 by stepone68 Depends on what fx rates analysts have been using in their forecasts, and how much they have changed. Possibly not that much (i.e. they were already lower than spot rate). Plus other companies will also benefit from the weak pound, not just BVXP. Read Full Thread Follow Reply
Posted at 28/3/2022 09:21 by piedro Interims ... "Board is pleased to announce a first interim dividend of 52p per share which represents a 20% increase on the interim dividend paid last year (43 pence per share). The shares will be marked ex-dividend on the 7 April 2021 and the dividend will be paid on 22 April 2021 to shareholders on the register at close of business on 8 April 2021." !! Read Full Thread Follow Reply
Posted at 21/11/2021 16:15 by tmfmayn BIOVENTIX: FY 2021 Results Unveil Record H2 Profit (+14%) While Finite Troponin Income Shifts Longer-Term Perspective Towards Pyrene Project And Alzheimer’s Research #BVXP  "Valuing the pipeline at a negative £5m seems about right if annual R&D costs are £1.2m and research commercialisation is not expected until 2025 at the earliest" hTTps://maynardpaton.com/2021/11/05/bioventix-fy-2021-results-unveil-record-h2-profit-14-while-finite-troponin-income-shifts-longer-term-perspective-towards-pyrene-project-and-alzheimers-research/ Read Full Thread Follow Reply
Posted at 11/11/2021 16:02 by jonut Full list of bvxp rns's here, https://www.investegate.co.uk/Index.aspx?searchtype=3&words=bvxp Read Full Thread Follow Reply
Posted at 11/11/2021 15:44 by gnnmartin I hoped to find the latest BVXP presentation to investors, but I can't find anything later that 2019. I expected to find it on the BVXP web site, but that gives surprisingly little information. Can anyone tell me where I can find what I seek? Read Full Thread Follow Reply
Posted at 19/10/2021 14:26 by stepone68 I suppose the key thing is that there is 1.2m of revenue which will not be in future results. Troponin is roughly half of that level. Even if it doubles again this year, we will be down overall, so we need Vitamin D to return to growth. There are a lot of things I like about this company - the long royalty terms, the simple results, the low cost of sales, being in the healthcare sector, the dividend and the quick dividend turn around time (ex divi next week and paid 2 weeks later). But it is highly rated so I think share price growth will be limited from here on (unless Troponin really takes off). Read Full Thread Follow Reply
Posted at 19/10/2021 10:34 by shouldhavesold That’s daft. It’s the yield on current price that’s the only thing worth considering Otherwise how do you compare with alternatives for your money etc. You could have an investment 50yrs old paying 5000% on your purchase price - means nothing if it’s 1% on the current value Compare like with like Look to the future, not the past The yield here is good though Read Full Thread Follow Reply
Posted at 18/10/2021 15:01 by apad I paid 3854p for BVXP this morning. Averaging up, so my yield will reduce 😊 My thinking was that I expected them to be suffering more than they are and previously they have been marked down on opening only to recover as folks find something to be pleased about. Anyroadup they are 3910 to buy at the moment, so not much of an effect. apad BTW I have also observed them being marked down on the ex div morning and then ambling up during the day. Read Full Thread Follow Reply
Posted at 18/10/2021 14:36 by stepone68 It's fine to talk about yield on your purchase price but you should also value your holding at that price. Otherwise you are trying to have your cake and eat it. Read Full Thread Follow Reply
Posted at 18/10/2021 09:50 by apad BVXP troponin sales doubled. Maybe this is a significant increase given the state of hospitals. No comment on the Point of Care tests as a competitor. Easy to hold on a 7% yield. "Over the next few years, the commercial development of the new troponin assays will have the most significant influence on Bioventix sales. There are currently no antibodies in the future pipeline that are comparable to our troponin products in potential value and the ability to influence revenues in the next few years." apad Read Full Thread Follow Reply

Bioventix share price data is direct from the London Stock Exchange

Advertise Here

Your Recent History

LSE

BVXP

Bioventix

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US

P: V: D:20220929 15:03:09